Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
Amanda Bynes Flaunts Slimmer Physique After Ozempic Use - Featured image
Entertainment

Amanda Bynes Flaunts Slimmer Physique After Ozempic Use

Amanda Bynes recently displayed a noticeably slimmer figure while out in Los Angeles. Bynes has openly discussed her weight-loss journey, which she initiated in June with the help of Ozempic.

Shotlee·December 15, 2025·Updated Feb 2, 2026·3 min read
Share:

Amanda Bynes Flaunts Slimmer Physique After Ozempic Use

Amanda Bynes showcased a noticeably slimmer figure while running errands in Los Angeles recently.

The actress, who will turn 40 next April, sported black leggings, a colorful striped T-shirt, a white tote bag, and matching jelly shoes.

Bynes has been vocal regarding her weight-loss journey, which she began in June using Ozempic, a GLP-1 agonist drug, with the aim to 'look better in paparazzi pictures.'

On November 5, she announced, 'I've lost 20 pounds so far. I'm so excited about that to be honest. Also, I want to lose about 50 more pounds.' She added, 'I'm 163 now -- I actually shot up on the Ozempic pill to 180 from 173, so I was able to lose 20 pounds from 180, and now, I'm down to 163 on the Ozempic injection.'

Bynes continued by saying the injection is 'really working for me, and I'm trying to lose more weight just to feel skinny and cute.'

On October 23, she revealed she was also exercising by attending a '7:15am Pilates class.'

Back in 2018, Bynes told Paper Magazine she was 'abusing Adderall' in 2006 to maintain her slim figure, referring to it as 'the new skinny pill'.

The FDA has approved only three GLP-1 drugs specifically for weight loss: semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound). The remaining drugs are intended for patients with type 2 diabetes.

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

Several celebrities have admitted to using diabetic injectables, including Oprah Winfrey, Kathy Bates, Kelly Clarkson, Whoopi Goldberg, Serena Williams, Amy Schumer, Meghan Trainor, Elon Musk, Rebel Wilson, Chelsea Handler, Sharon Osbourne and Tori Spelling.

There are also celebrities who have remained silent while slimming down, including Selena Gomez, Mindy Kaling, Melissa McCarthy, Khloé Kardashian, Demi Lovato, Lana Del Rey, Christina Aguilera and Ricki Lake.

Last month, Bynes addressed an altered TikTok video in which she accused her former boss Dan Schneider of getting her pregnant at 13, clarifying to TMZ that these were 'lies for click bait.'

In the 2024 Quiet on Set docuseries, Schneider was accused of inappropriate behavior by several former actors. He is currently suing the creators and others for defamation, claiming they falsely implied he sexually abused child actors.

Bynes' nine-year legal conservatorship, controlled by her mother, ended in 2022. However, she was hospitalized at a psychiatric treatment facility in 2023 after spending four days wandering the streets in a manic state. Health tracking apps like Shotlee can help monitor individuals in similar situations and provide support.

She was previously hospitalized in 2013 after a public meltdown that involved a string of run-ins with the law dating back to 2012, including two hit-and-runs and two DUIs.

Bynes previously pursued her manicurist license and earned an associate degree from the Fashion Institute of Design & Merchandising in 2019.

Original source: Daily Mail Online

View original article →
#Amanda Bynes#Ozempic#weight loss#celebrity weight loss#GLP-1 drugs
  1. Home
  2. Blog
  3. Amanda Bynes Flaunts Slimmer Physique After Ozempic Use

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community